Fever of unknown origin in rheumatic diseases;Febbri di origine oscura in reumatologia

Recenti Progressi in Medicina

Volumn 89, Issue 1, 1998, Pages 30-36

  Fioravanti, Antonella ^a,b   Montemerani, Marella ^a   Scola, Cesare ^a   Minari, Chiara ^a   Bellisai, Francesca ^a   Pipitone, Nicolò ^a   Cicero, Maria Rosaria ^a   Marcolongo, Roberto ^a  

^a UNIVERSITY OF SIENA   (Italy)

^b UNIVERSITY HOSPITAL OF SIENA   (Italy)

Author keywords

Fever of unknown origin; Interleukin; Rheumatic diseases

Indexed keywords

INTERLEUKIN 1; INTERLEUKIN 6; TUMOR NECROSIS FACTOR;

ARTHROPATHY; CLINICAL EXAMINATION; CONNECTIVE TISSUE DISEASE; HUMAN; PYREXIA IDIOPATHICA; REACTIVE ARTHRITIS; REVIEW; RHEUMATIC DISEASE; SYMPTOM;

ADULT; ARTHRITIS; ARTHRITIS, INFECTIOUS; ARTHRITIS, JUVENILE RHEUMATOID; ARTHRITIS, RHEUMATOID; CHILD; CHRONIC DISEASE; CONNECTIVE TISSUE DISEASES; DRUG THERAPY; FEVER OF UNKNOWN ORIGIN; GOUT; HUMANS; RHEUMATIC DISEASES; STILL'S DISEASE, ADULT-ONSET;

EID: 0031888666     PISSN: 00341193     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (43)

1. Petersdorf RG, Beeson PB. Fever of unexplained origin: report of 100 cases. Medicine 1961; 40: 1-30.
2. Smith JW. Southwestern Internal Medicine Conference: Fever of undeterminated origin: not what it used to be. Am J Med Sci 1986; 292: 56-64.
3. Baracos V, Rodemann HP, Dinarello CA, Goldeberg AL. Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin 1): a mechanism for the increase degradation of muscle proteins during fever. N Engl J Med 1983; 308: 553-8.
4. Dinarello CA. Interleukin 1 and the pathogenesis of the acute phase response. N Engl J Med 1984; 311: 1413-8.
5. Milton AS, Wendlant S. Effect on body temperature of prostaglandins of the A, E and F series on injection into the third ventricle of anesthetized cats and rabbits. J Physiol 1971; 218: 325-33.
6. Rutanen EM, Teppo AM, Stenman UH, et al. Recurrent fever associated with progesterone action and persistently elevated serum levels of immunoreactive tumor necrosis factor-2 and interleukin-6. J Clin Endocr Metab 1993; 76: 1594-8.
7. Saxema PN, Beg MM, Singhal KC, Ahmad M. Prostaglandin-like activity in the cerebrospinal fluid of febrile patients. Indian J Med Res 1970; 70: 495-9.
8. Bocci V. Possible cause of fever after interferon administration. Biomedicine 1980; 32: 159-61.
9. Weinberger A, Aderka D, Pinkhas J. Systemic lupus erythematosus: a state of hyperinterferonemia. Medical Hypotesis 1982; 9: 369-73.
10. Weinberger A, Kesler A, Pinkhas J. Fever in various rheumatic diseases. Clin Rheumat 1985; 4: 258-66.
11. Martin K, Davies EG, Axford JS. Fever of unknown origin in childhood: difficulties in diagnosis. Ann Rheumat Dis 1994; 53: 429-33.
12. Calabro JJ, Marchesano JM. Rash associated with juvenile rheumatoid arthritis. J Ped 1968; 72: 611-9.
13. Bywaters EGL. Still's disease in the adult. Ann Rheumat Dis 1971; 80: 121-33.
14. Stahl NI, Klippel JH, Decker JL. Fever in systemic lupus erythematosus. Am J Med 1979; 67: 935-40.
15. nd ed Southern California Press 1974; 257-8.
16. Harvey AM, Shulman LE, Tumulty PA, Conley CL, Schoenrich EH. Systemic lupus erythematosus: review of the literature and clinical analysis of 138 cases. Medicine 1954; 33: 291-337.
17. Sharp GC, Irwin XS, Tan EM, et al. Mixed connective tissue an apparently distinct rheumatic disease syndrome associated with a specific antibody to extractable nuclear antigen. Am J Med 1972; 52: 148-59.
18. Bennet RM, O'Connell DJ. Mixed connective tissue disease: a clinicopathologic study of 20 cases. Semin Arthritis Rheum 1980; 10: 25-51.
19. Bombardieri S, Moutspoulos HM. Workshop on diagnostic criteria for Sjögren's syndrome. Clin Exp Rheumatol 1989; 7: 185-90.
20. Pearson CM. Rheumatic manifestation of polymyiositis and dermatomyositis. Arthritis Rheum 1959; 2: 127-43.
21. Berliner S, Shoenfeld Y, Weinberger A, Pinkhas J. Polyarteritis nodosa-survey of 26 patients. Rev Int Rheumatol 1977; 7: 137-44.
22. Wolff SM, Fauci AS, Horn RG, Dale DC. Wegener's granulomatosis. Ann Int Med 1974; 81: 513-25.
23. Weinberger A, Berliner S, Pinkhas J. Articular manifestations of essential cryoglobulinemia. Semin Arthritis Rheum 1981; 3: 224-9.
24. Allen DM, Diamond LK, Howell DA. Anaphylactoid purpura in children (Henoch-Sehönlein syndrome). Am J Dis Child 1960; 99: 833-37.
25. Ueno Y, Takano N, Kanegane T, et al. The acute phase nature of interleukin-6: studies in Kawasaki disease and other febrile illnesses. Clin Exp Immunol 1989; 76: 337-42.
26. Waern AU, Andersson P, Hemmingsson A. Takayasu's arteritis: a hospital region based study on occurence, treatment and prognosis. Angiology 1983; 34: 311-20.
27. Calamia KT, Hunder GG. Giant cell arteritis (temporal arteritis) presenting as fever of undeterminated origin. Arthritis Rheum 1981; 24: 1414-9.
28. Von Knorring G, Erma M, Lindstrom B. The clinical manifestation of temporal arteritis. Acta Med Scand 1966; 169: 691-701.
29. Jones JG, Harleman BL. Polymialgia rheumatica and giant cell arteritis. A difficult diagnosis. J R Coll Gen Pract 1981; 31: 283-9.
30. Lapadula G, Covelli M. La clinica delle artriti reattive: il pattern articolare. Reumatismo 1990; 3: 173-83.
31. Young EJ. Human brucellosis. Rev Infect Dis 1983; 5: 821-823.
32. Rhan DW. Lyme disease: clinical manifestations, diagnosis and treatment. Semin Arthritis Rheum 1990; 20: 201-18.
33. Jones criteria (revised) for guidance in the diagnosis of rheumatic fever. Circulation. 1965; 32: 664-670.
34. Goldenberg DL, Reed JL. Bacterial arthritis. N Engl J Med 1985; 312: 764-71.
35. Weiss TE, Segaloff A. Gouthy arthritis and gout. Springfield: Ch Thomas 1959; 65-70.
36. Berger RG, Levitin PM. Febrile presentation of calcium pyrophosphate dihydrate deposition disease. J Rheumatol 1988; 15: 642-3.
37. Mayock RL, Bertrand P, Morrison CE, et al. Manifestations of sarcoidosis. Am J Med 1963; 35: 67-73.
38. Garcia-Gonzalez A, Weisrnan MH. The arthritis of Familial Mediterranean Fever. Semin Arthritis Rheum 1992; 22: 139-50.
39. Burnum JF. Preventability of adverse drug reactions. Ann Int Med 1976; 85: 80-1.
40. Mackowiak PA, Lemaistre CF. Drug fever: a critical appraisal of conventional concepts. An analysis of 51 episodes in two Dallas hospitals and 97 episodes reported in the english literature. Ann Int Med 1987; 106: 728-33.
41. Lipsky BA, Hirschmann JV. Drug fever. J Am Med Ass 1981; 245: 851-4.
42. Segar WE, Hollyday MA. Physiologic abnormalities of salycilate intoxication. N Engl J Med 1988; 259: 1191-93.
43. Semel JD. Fever on drug free day of alternate-day steroid therapy. Am J Med 1984; 76: 315-7.